These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
150 related items for PubMed ID: 24287754
1. Cost of epilepsy care in a Nigerian tertiary hospital. Sanya EO, Kolo PM, Adekeye A, Mustapha K, Ademiluyi BA, Ajayi K. Niger Postgrad Med J; 2013 Sep; 20(3):218-22. PubMed ID: 24287754 [Abstract] [Full Text] [Related]
10. Medical care costs of newly diagnosed children with structural-metabolic epilepsy: a one year prevalence-based approached. Salih MR, Bahari MB, Shafie AA, Hassali MA, Al-lela OQ, Abd AY, Ganesan VM. Seizure; 2012 Dec; 21(10):764-9. PubMed ID: 22939458 [Abstract] [Full Text] [Related]
12. Cost-effectiveness analysis for the use of serum antiepileptic drug level monitoring in children diagnosed with structural-metabolic epilepsy. Salih MR, Bahari MB, Shafie AA, Hassali MA, Al-Lela OQ, Abd AY, Ganesan VM. Epilepsy Res; 2013 Mar; 104(1-2):151-7. PubMed ID: 23103061 [Abstract] [Full Text] [Related]
13. Estimating the cost of epilepsy in Europe: a review with economic modeling. Pugliatti M, Beghi E, Forsgren L, Ekman M, Sobocki P. Epilepsia; 2007 Dec; 48(12):2224-33. PubMed ID: 18088267 [Abstract] [Full Text] [Related]
14. Economic cost of treatment of childhood epilepsy in Enugu, southeast Nigeria. Ughasoro MD, Onwujekwe OE, Ojinnaka NC. Int J Technol Assess Health Care; 2014 Oct; 30(4):469-74. PubMed ID: 25425239 [Abstract] [Full Text] [Related]
15. [Survey of adults living with epilepsy in Hungary: health-related quality of life and costs]. Péntek M, Bereczki D, Gulácsi L, Mikudina B, Arányi Z, Juhos V, Baji P, Brodszky V. Ideggyogy Sz; 2013 Jul 30; 66(7-8):251-61. PubMed ID: 23971356 [Abstract] [Full Text] [Related]
16. Economic burden associated with the use of generic antiepileptic drugs in the United States. Helmers SL, Paradis PE, Manjunath R, Duh MS, Lafeuille MH, Latrémouille-Viau D, Lefebvre P, Labiner DM. Epilepsy Behav; 2010 Aug 30; 18(4):437-44. PubMed ID: 20580619 [Abstract] [Full Text] [Related]
17. Neurologist adherence to clinical practice guidelines and costs in patients with newly diagnosed and chronic epilepsy in Germany. Strzelczyk A, Bergmann A, Biermann V, Braune S, Dieterle L, Forth B, Kortland LM, Lang M, Peckmann T, Schöffski O, Sigel KO, Rosenow F. Epilepsy Behav; 2016 Nov 30; 64(Pt A):75-82. PubMed ID: 27732920 [Abstract] [Full Text] [Related]
18. Burden of epilepsy: a prevalence-based cost of illness study of direct, indirect and intangible costs for epilepsy. Gao L, Xia L, Pan SQ, Xiong T, Li SC. Epilepsy Res; 2015 Feb 30; 110():146-56. PubMed ID: 25616467 [Abstract] [Full Text] [Related]
19. Impact of nonadherence to antiepileptic drugs on health care utilization and costs: findings from the RANSOM study. Faught RE, Weiner JR, Guérin A, Cunnington MC, Duh MS. Epilepsia; 2009 Mar 30; 50(3):501-9. PubMed ID: 19183224 [Abstract] [Full Text] [Related]
20. Economic burden of epilepsy in India. Thomas SV, Sarma PS, Alexander M, Pandit L, Shekhar L, Trivedi C, Vengamma B. Epilepsia; 2001 Aug 30; 42(8):1052-60. PubMed ID: 11554893 [Abstract] [Full Text] [Related] Page: [Next] [New Search]